JSPR:NASDAQ, Jasper Therapeutics, Inc.

Why JSPR stock rose on November 6

Jasper Therapeutics, Inc. rose 19.8% on Friday, November 6, 2026, on 63,400 shares, 3.6 times its average daily volume. No headline about JSPR came out that day or the day before in the news feeds we follow, so the move may come from news we don't track, the sector or trading alone.

JSPR stock overview

Jasper Therapeutics, Inc. (JSPR:NASDAQ) closed at $14.75 on November 10, 2026, down 9.90% on the day. The stock trades 79.7% below its 52-week high of $72.60 and 56.1% above its 52-week low of $9.45. Over the past year, it lost 67.9%. Jasper Therapeutics, Inc. is part of the Finance sector.

Key figures

Price
$14.75
Day change
-9.90%
Volume
46,697
Average volume
17,649
Market cap
16M+
52-week range
$9.45 – $72.60
50-day average
$17.34
200-day average
$24.62

Price action over the past year

In 252 trading sessions since November 10, 2025, JSPR closed higher on 117 days (46%). Its best day was June 29, 2026 (+23.17%) and its worst was June 1, 2026 (-35.59%). The stock moved 10% or more in a single session 23 times. It opened at least 5% above the previous day's high 3 times.

Recent signals

JSPR news

About Jasper Therapeutics, Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Similar stocks

Find more stocks like JSPR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.